(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 4.33% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Bruker's revenue in 2026 is $3,499,600,000.On average, 16 Wall Street analysts forecast BRKR's revenue for 2026 to be $552,607,239,132, with the lowest BRKR revenue forecast at $529,753,341,732, and the highest BRKR revenue forecast at $571,804,512,948. On average, 16 Wall Street analysts forecast BRKR's revenue for 2027 to be $575,004,058,584, with the lowest BRKR revenue forecast at $546,208,147,860, and the highest BRKR revenue forecast at $602,276,376,148.
In 2028, BRKR is forecast to generate $607,456,592,892 in revenue, with the lowest revenue forecast at $571,499,794,316 and the highest revenue forecast at $646,765,296,420.